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How Stress Impacts Cancer Patients 
Ally Montanez 
 
 Cancer is not a word taken lightly in any sense—people 
respect the weight that comes with it and realize that this life-
taking disease is not a joking matter. Cancer patients are under 
a lot of stress: fighting for their lives and all that such a battle 
entails, from doctors’ appointments to difficult prognoses to 
expensive bills, all while trying to go about their daily lives as 
normally as possible. Even for healthy individuals, healthcare 
on its own is very expensive. In the United States in 2017, 
Americans spent about $3.5 trillion, or almost $11,000 per 
person, on healthcare, a 3.5 percent increase from 2016 
(Center for Medicare & Medicaid Services, 2020). 
Unfortunately, rates of cancer are rising in the United States. 
According to the American Cancer Society, there were an 
estimated 609,640 cancer deaths in the United States in 2018 
(American Cancer Society, 2018). That number might not 
seem so bad in comparison to rates of other forms of mortality 
in the United States, but the sad and painful reality of cancer is 
that it does not care whose life it invades. 
Indeed, Jaimi McIlraith—my mother—was one of 
those 609,640 souls lost in 2018 to cancer; she died December 
14, 2018, from melanoma. In summer 2015, her doctors found 
melanoma, and over the span of her battle with cancer, the 
tumors spread from her skin to her lungs, her lymph nodes, 
and finally her abdomen. The tumors ranged in size from as 
small as a grain of sand to as large as a grapefruit. Even when 
they were removed, they returned within a month, and with 
full vengeance. At the time of her death, my mother was only 
40 years old. She was a beautiful mother who would have done 
absolutely anything for her two daughters. 
Throughout her fight against cancer, and something 
that I noticed, was her emphasis on keeping stress at bay, 
always telling my sister and me, “Stress feeds the cancer in my 
body.” After my mother’s passing, her doctors could not give a 
medically-based answer as to why she lived for so long, from 
diagnosis in 2015 to her passing in 2018, with Stage IV 
melanoma. I wondered, “What helped her persevere and 
persist despite the odds?” 
As her battle with cancer was nearing its end, I was a 
first-year student completing my first semester of college 
courses, including Composition I. Yearning for an answer to 
my question about her atypical perseverance, I took the 
opportunity of class assignments to research the impact of stress 
on cancer. I began at the beginning, when she was first 
diagnosed with melanoma, and I began to retrace what she 
explored and learned, using her own words as shared in real 
time on her social media and preserved forever as artifacts on 
her Facebook page, as she lived with her diagnosis. In the same 
way I conducted research for my own college classes, she 
conducted research on her own situation; as I studied and 
followed her trail of research and study, I concluded that she 
was absolutely right in maintaining that stress was directly 
linked with the progression of cancer. 
Yet too often, too many healthcare professionals 
overlook the priority of psychological well-being in patients 
diagnosed with cancer, just as too many healthcare 
professionals discount the knowledge and understandings that 
their patients bring to their diagnoses. By implementing more 
treatments for cancer patients involving their mental well-
being, stress can be reduced significantly, slowing the cancer’s 
growth in the body and increasing the overall quality of life for 
the patients. 
 When I began my research, I wanted to define my 
terms so as to have a concrete foundation on which to argue 
that stress exacerbates cancer. As Vasile (2016) writes, 
“[C]ancer is a group of diseases in which cells have the ability 
to invade surrounding tissue and present a potential risk of 
metastasis in other distant areas of the body” (p. 74). Stress is 
defined medically, by Sillamy (1998), as “the condition in 
which there is a body threatened by imbalance under the threat 
of agents or conditions that endanger its homeostatic 
mechanisms” (as cited in Vasile, 2016, p. 75). Stress causes 
physical reactions in the human body, whether it be as simple 
as a headache or as detrimental as weakening the immune 
system and allowing the body to become more susceptible to a 
more rapid growth rate of cancer in the body. A study 
conducted by scientists and psychologists at the Columbia 
University Medical Center in New York City proved that stress 
causes an accelerated rate of cancer growth and development. 
They conducted their study on mice and found that the 
hormones that were released by the stress caused this rapid 
development of pancreatic cancer in the mice (Printz, 2018). 
Cancer is, from my experience, a threat to the very core of a 
person due to the unknown future ahead. We did our best as a 
family to stay cohesive, although we did fail at times due to 
personal stressors overcoming us. 
After her diagnosis in 2015, my mother shared publicly 
on social media her 
personal thoughts on 
how much her life 
changed in various 
aspects. As Nelson 
(2018b) emphasizes, 
“Cancer is hard. It is 
exhausting physically, 
emotionally, mentally 
and financially.” Such 
is a reality my mother 
captures in Figure 1, 
when she had been 
diagnosed for just 
over three years. She 
even noted that she 
tries “to keep a 
positive outlook on 
everything that comes 
[her] way health 
wise” (Nelson, 2018b), 
meaning that my 
mom found the value 
Figure SEQ Figure \* ARABIC 1: Jaimi Nelson shares a peek 
into her life with friends and family on Facebook and let’s them 
know how her cancer is affecting in a very personal way (Nelson, 
“Life with Cancer”). 
behind having a 
positive mindset to 
be very powerful 
in her fight against 
cancer. That 
positive mindset 
can be seen as she 
says that if 
someone were 
already not in a 
positive state of 
mind and received 
such negative 
news as she was, 
she does not see 
how they could do 
anything other 
than completely 
fall to pieces in 
devastation 
(Nelson, 2018b). 
As cancer grows within the body, it can cause physical 
pain because it is wearing down the healthy cells, whether they 
be bone cells or the cells of an organ (Cooper, 1988, pp. 114-
115). The surgery she references in Figure 2 was the operation 
she had in June 2018. My mother had massive tumor growth 
within her abdomen. Her tumors were growing to be large and 
aggressive, but the body does not have that much extra room to 
spare to allow these growths to exist peacefully. Rather, she felt 
them pushing up against organs which caused violent pain in 
her life, decreasing her desire to do anything with too much 
physical activity in fear of moving too much and initiating the 
pain to start all over again. Along with the larger tumors, she 
also had smaller ones scattered throughout her abdomen and 
even a fluid filled with tumors so tiny they were compared to 
“grains of sand” by the doctors in the operating room. My 
mother made a point of looking forward to not being in pain, 




her power to rid 
her body of 
tumors, but even 
though the 
surgery was a 
success at the 
time and the 
doctors claimed 
to have removed 
everything from 
her abdomen, 
when she went to 
the doctor less 
than three weeks 
post-surgery 
thinking she had an incisional hernia, it was actually the cancer 
coming back full vengeance. After receiving scan results in 
August 2018, my mother reached out to her Facebook friends 
and family for prayers as she and her doctors at Cancer 
Treatment Center of America all did research to find a next-
best option (Figure 3). She admitted to everyone reading the 
post that she knew she was unable to continue working her job 
as a preschool teacher because of the level of pain she was 
undergoing, but due to my mother’s resiliency and peace she 
had in her heart, she still remained completely hopeful and 
wanted to be the best mother she could be (Nelson, 2018c). I 
firmly believe that my mother’s positive outlook on life and 
faith in God got her through the roughest of nights.  
Integrative care is highly important for cancer patients 
because it gives them non-traditional options to target things in 
their lives other than merely the cancer itself. My mother 
started going to the Cancer Treatment Centers of America 
(CTCA) in 2018 in Atlanta, Georgia, when she made the 
choice that Duke Cancer Center was not giving her any more 
options about how she could fight cancer in a way that would 
both prolong her life and allow her to keep a quality of life that 
she was comfortable with. Dr. Stacie Stephenson, CTCA Chair 
of Functional Medicine, said, “An integrative approach to 
cancer care treats the disease with surgery, chemotherapy and 
other conventional tools, while also supporting patients’ 
strength, stamina and quality of life with evidence-informed 
therapies” (Cancer Treatment Centers of America, 2021b). 
One of these integrative care treatment options targets stress 
and anxiety in the life of the cancer patient. CTCA offers music 
therapy, guided image therapy, time with emotional support 
animals, and spiritual counseling and teaches their patients 
ways to reduce stress through various techniques to adapt into 
everyday life, such as including something to make you laugh 
every day to reduce stress-related hormones within the body 
(Cancer Treatment Centers of America, 2021a). My mother 
was offered a larger variety of treatments at CTCA that 
allowed her to make the choice she felt and had researched and 
prayed about to prolong her life and possibly improve, or at 
least maintain, her quality of life. Through the hard work and 
dedicated staff at CTCA, my mother was able to receive better 
quality treatments, medications, and operations that Duke 
Cancer Center was unable to provide for her. 
Another method of treating cancer encouraged by 
CTCA is allowing the body quite literally to heal itself by 
drastically changing one’s diet to consuming only things that are 
beneficial to the body that will fight cancer. My mom was an 
advocate for eating healthy and allowing the body to heal itself 
at the start of her cancer fight—instead of pumping her body 
full of chemicals, she altered her diet and saw results that the 
doctors claimed they could not explain. However, we know 
that it was her all natural diet and stress relief methods that 
kept her alive as long as she was here for. CTCA also offers 
spiritual care for their patients who may be wondering what 
happens after this life ends on the earth. My mom was heavily 
involved in church from an early age, but I personally noticed 
her being a lot more vocal about her faith and how she was 
seeing the hand of God working in her life and in her fight 
against cancer after she was diagnosed. My mom also had a lot 
of faith in counseling and praying, which also goes hand in 
hand with techniques of stress relief, which improve the body’s 
health. She and the pastor of our church and his wife would 
have several talks about what heaven was like. They would 
pray together over my mom for her and our family to 
experience peace and feel the hand of God in our home and 
lives during this time of unexplainable pain.  
Throughout her experience with cancer, music was a 
huge outlet for my mom, which also went hand in hand with 
her faith in God because she listened to the songs by Christian 
artists that were reassuring of God’s love and his plan for our 
lives. Her absolute favorite artist was Lauren Daigle, a faith-
driven woman who writes music for those who are 
experiencing trials within their lives. Lauren Daigle’s song, 
“You Say,” was a powerful song for my mother because of the 
words and their meaning to her personally. The words “Taking 
all I have, and now I’m laying it at Your feet / You have every 
failure, God, You have every victory” (Daigle, 2018), were her 
anthem during the worst of her battle with cancer. Music was 
almost a way of meditation for her that could be infused with a 
task as simple as driving to work in the morning. By hearing 
these faith-filled words, she was inspired to keep up her fight 
with cancer, but she ultimately knew that God had the best 
plan in mind for her life. Her faith in God’s timing is evident in 
her posts and the lyrics in the songs she filled her life with. 
“Thy Will Be Done” by Hillary Scott & The Scott Family 
(2016) was another song we would often hear in our home 
several times a day due to the message it carries. The lyric that 
“I may never understand / That my broken heart is a part of 
your plan” (Hillary Scott & The Scott Family, 2016) is one of 
the most impactful phrases in the entire song, due to its 
ultimate surrender through trust in Him despite not knowing 
the road ahead of her. The very title of the song proclaimed 
her firm trust in God, which granted her peace beyond 
understanding because even though she was not sure of what 
was coming, she knew it was meant to be and would not doubt 
God or His love. Another set of lyrics—”I know You see me / I 
know You hear me, Lord. / Your plans are for me / Goodness 
You have in store” (Hillary Scott & The Scott Family, 2016)—
evokes tears because of the message it brings. She prayed for 
her life, and she had many others who did the same, but she 
had the peace in knowing whatever will be will be because He 
has a greater plan in store for our lives. Since my mom has 
passed away, her story has been heard by so many people, and 
it has truly been a blessing to know that because of her life and 
advocacy for alternative treatments, she gave so many people 
the opportunity to see what removing stress in one’s life can 
truly do to benefit their lives.  
By witnessing my mother’s fight against cancer, I 
learned a lot and became inspired to learn more. I also wanted 
to share as widely as possible what I and so many others have 
come to know, how stress can cause physiological changes in 
the bodies of individuals diagnosed with terminal cancer, and 
that there are so many reasons for psychologists and oncologists 
alike to start co-implementing psychological and medical 
treatment solely for the cancer patient. It has been proven to 
improve the overall mindset and mental wellness of the patient, 
and by having a healthy mindset, a patient is more equipped to 
take on the challenges that cancer will throw their way. By 
analyzing the life of my mother who beat stage 2b breast 
cancer, but died of stage IV melanoma, we are able to better 
understand how stress can play a role in the life of a cancer 
patient. And by delving into the research of the individuals 
whose chapters follow mine in this collection, we can see 
firsthand the power of psychological strength and support, the 
assault of stress, and the critical importance of supporting 
individuals’ mental wellbeing throughout their diagnosis of 
cancer. 
Emphasizing psychological strength and support means 
rethinking the contemporary practice of medicine in the 
United States. In “Nurse Practitioner Knowledge and Use of 
Complementary and Alternative Therapies for the 
Management of Chronic Musculoskeletal Pain: A Pilot Study,” 
Courtney Phillips focuses on the medical side of this issue. Not 
only are prescription drugs easily manipulated into life-
threatening addictions, Phillips notes; their preponderance 
avoids a fundamental ailment of the patient: their mental and 
emotional wellbeing. By taking a stronger step toward greater 
inclusion of alternative medications and treatments, patients 
can expect to experience an overall increase in their mental 
health and decrease in stress, which in turn can have an impact 
on their physical health as well. From the sample in this study, 
Phillips makes evident that most nurse practitioners do not feel 
adequately informed about these alternative treatments, which 
means they almost never recommend them to the patients they 
see on a regular basis.  
In “Anxious People Report Less Emotional Distancing 
While Imagining Negative Future Events,” Cameron Scroggs 
explores the long-term effects of chronic stress on patients. 
Scroggs focuses on internally generalized thoughts as a way to 
safely consider the unknown future ahead and how their 
thinking process can become semantic when someone places 
too much pressure on themselves due to overthinking on the 
potential threat. These types of thoughts can be intrusive to the 
individuals’ daily lives, as well as not offer any reasonable 
solution, which only adds to their overall suffering. 
Indeed, a battle that patients with chronic illness endure 
is the silent battle of mental illness within their own minds. In 
“Investigating the Relationship Between Anxiety Sensitivity 
and Chronic Illness: A Replication and Extension,” Emily 
Berdal takes a deep dive into the real issue of comorbidity of 
mental illnesses and chronic ailments. These comorbid 
diagnoses often tend to prevent the debilitating condition from 
fully being resolved due to the focus being placed solely and 
primarily on physical, not mental, health. Berdal’s research 
points to the fact that those who are diagnosed with both a 
chronic illness and a mental illness will experience worse 
symptoms of the chronic illness than those who do not have 
both diagnoses. According to the data shown in prior research 
along with Berdal’s as well as my own, mental health needs to 
be prioritized just as much as physical health is because it is 
proven to have a direct impact on our bodies.  
Mental health and a positive outlook on life is vital to 
those who have to undergo so much in efforts to save their 
lives. Not only are they undergoing the stressors of their 
treatments, appointments, and their prognosis; unfortunately, 
they also are not spared from the daily stressors that everyone is 
exposed to, such as how to make ends meet, who’s cooking 
dinner, getting the kids to and from practice, and so much 
more that varies on an individual basis. Having a positive 
outlook goes a long way in the life of a cancer patient. Cancer 
patients undergo a bounty of stress solely dealing with their 
health, and they do not need to have to combat the stress of a 
normal life as well. By offering alternative treatments to cancer 
patients, many lives will be prolonged, if not saved, due to the 
removal of stress in their lives that allows them to focus on 
saving their lives from this disease.  
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Nurse Practitioner Knowledge 
and Use of Complementary and Alternative 
Therapies for the Management of Chronic 
Musculoskeletal Pain: A Pilot Study 
Courtney Phillips 
 
Over-prescription and misuse of opiates in the 
treatment of chronic musculoskeletal pain (CMP) in adults can 
result in patients becoming dependent on opiates for pain 
relief. As dependency builds, so does tolerance, requiring a 
higher prescribed dose in order to achieve the desired effect. 
According to the National Institute on Drug Abuse (NIDA) 
(2021), roughly 21-29% of patients prescribed opioids for 
chronic pain misuse them. Between 8 and 12% of those 
individuals develop an opioid use disorder (NIDA, 2021).  The 
Diagnostic and Statistical Manual of Mental Disorders, 5th 
Edition (DSM-5) defines opioid use disorder as “a problematic 
pattern of opioid use leading to clinically significant 
impairment or distress” (APA, 2013).  In order to be diagnosed 
with opioid use disorder, clinical impairment must be 
manifested by at least two DSM-5 criteria within a 12-month 
period. These criteria include using large amounts of opioids 
over a longer period than intended; reducing social, 
occupational, or recreational activities due to opioid use; 
continued use of opiates despite physical or psychosocial harm; 
and experiencing tolerance and/or withdrawal. 
The treatment of chronic pain requires a multifaceted 
approach. Improper prescribing practices have been a 
contributing factor to the current opioid epidemic. Some 
providers are reluctant to encourage the use of complementary 
and alternative approaches to treat chronic pain. 
Complementary and alternative medicine (CAM) therapies are 
a group of diverse medical and health care practices that are 
not considered to be a part of conventional medicine (U.S. 
National Library of Medicine, 2018). The use of CAM offers a 
new integrative approach to medicine that embraces the 
importance of the patient- provider relationship, focuses on the 
whole person, is informed by evidence, and makes use of all 
therapeutic approaches to achieve optimal health and well-
being (Andrew Weil Center for Integrative Medicine, 2021). 
Nurse practitioners (NPs) are in a position to educate 
their patients on the use of CAM therapies in order to 
minimize their use of prescription opiates. However, they must 
be knowledgeable of various CAM therapies in order to 
advocate for their use. The purpose of this feasibility study is to 
determine NP knowledge, treatment, and referral practices (if 
any) on the use of CAM to decrease the misuse of opiates in the 
treatment of chronic pain. 
 
Methods 
Data were gathered using a descriptive survey design to 
elicit the treatment and referral practices of NPs and their 
knowledge, beliefs, and attitudes pertaining to CAM. A survey 
comprising basic demographic information and open-ended 
questionnaires was delivered via Qualtrics online survey tool to 
a convenience sample of up to 20 practicing NPs. Prior to 
gathering participant data, approval by the University 
Institutional Review Board was obtained. In order to protect 
the privacy of subjects, no personal identifiers were collected 
and responses remained anonymous. 
 
Sample 
Fourteen NPs voluntarily participated in this study (n = 
14), all of whom held advanced practice degrees (6 had a 
master of science in nursing degree, 3 had a doctorate of 
nursing practice degree, and 5 had a doctor of philosophy 
degree). The mean number of years of experience as an NP 
was 9.64 years. Five NPs reported working in the acute care 
setting (n = 5; 35.71%), eight reported working in the 
outpatient setting (n = 8; 57.14%), and one was not currently 




Participant responses were categorized into three 
themes: (1) knowledge of CAM; (2) treatment practices for 
CMP; and (3) referral practices. 
 
Knowledge of CAM 
NPs were asked to rate their knowledge of CAM using a 
Likert scale as presented in Table 1. Although NPs are in 
ample positions to educate patients about various treatment 
options for CMP, these findings suggest that NPs are equipped 
with minimal to fair knowledge of CAM therapies. How their 
knowledge was obtained varied from course content while 
pursuing continuing education, to personal readings and 
interactions with colleagues. Each NP response provided a 
different definition of CAM. These definitions were centered 
around the concept of natural modalities, holistic approaches, 
alternative therapies, and practices that fall outside of 




NP Knowledge of CAM Therapies 
 












According to Table 2, the majority of participants were in 
agreement that CAM plays an important role in the treatment 
of various health conditions. When asked to list CAM 
therapies, the three most common responses were acupuncture, 








Very Important Essential 






Treatment Practices for CMP 
In light of the current opioid epidemic, we asked NPs to 
express their likelihood of prescribing an opioid for someone 
seeking treatment for CMP. Although most NPs (n = 8) were 
unlikely to prescribe an opioid, those who were neither likely 
nor unlikely (n = 2), slightly likely (n = 2), and moderately likely 
(n = 2) were evenly distributed. A majority of NPs (n = 10; 
71.43%) claimed to have made adjustments to their current 
opioid prescribing practices. One participant chose to exclude 
this answer in their responses. Although opioid prescribing 
guidelines vary by state, practitioners can individualize their 
own prescribing practices within state regulations. NPs 
reported reducing their prescription of opioids by encouraging 
nonpharmacological interventions such as hot/cold therapy, 
physical and occupational therapy, and rest alongside the use of 
a nonsteroidal anti-inflammatory (NSAID) such as Ibuprofen as 
a first line of treatment. If an opioid is warranted, an NP 
suggested using the lowest prescription strength scheduled for 
shorter periods (e.g., 2 days v. 5) or as needed. For those 
already receiving opioids as treatment for CMP, 
recommending CAM in adjunct to the use of an opioid can 
prove beneficial and assist in potentially decreasing the dose 
needed to manage CMP. If opioid use disorder is suspected, it 
is important to facilitate treatment while maintaining a 
therapeutic patient-provider relationship. 
 
Referral Practices 
While some (n = 5) NPs ask about CAM therapies 
during every patient visit, half (50%) of NPs reported only the 
occasional inquiry of CAM during yearly physicals. Although 
most (n = 9; 64.3%) NPs stated that they are likely to 
recommend the use of CAM to their patients, they also 
reported that their practice does not provide them with the 
resources in order to do so. Upon follow up when CAM 
therapies were incorporated into the treatment plan for those 
with CMP, a majority of patients (n = 9; 64.29%) reported 
being somewhat satisfied with treatment while some (n = 2) 
reported being extremely satisfied. 
 
Discussion 
Over-prescription and misuse of opioids in the 
treatment of chronic pain is a well-known clinical problem that 
can lead to dependency and opioid use disorder. The treatment 
of chronic pain is complex and requires a multidimensional 
approach due to each individual’s experiences with pain being 
unique. Although pharmacological pain relief (opioids) may 
sometimes be warranted, they are often prescribed without 
additional patient education on complementary or alternative 
treatments. As suggested by Mehl-Madrona et al. (2016), the 
use of CAM is effective in managing pain resulting in reduced 
doses of opioids or some individuals choosing to stop their use 
altogether. While CAM therapies such as chiropractics, 
acupuncture, massage, and yoga are effective in adjunct with 
pharmacological relief, there is a lifestyle change associated 
with their use for pain relief. Eaves et al. (2015) illustrated that 
although skeptical at first, the use of CAM therapies gives 
patients a sense of empowerment over their care and 
motivation to seek additional coping strategies to manage 
chronic pain. 
The integration of CAM therapies into conventional 
practice can be used to decrease the misuse of opiates in the 
treatment of chronic pain and improve quality of life. NPs 
embrace a holistic approach to care, implementing diverse 
cultural beliefs into the care they provide. Although 
pharmacologic strategies are effective, prescribing opioids for 
the treatment of CMP does not contribute to the goal of 
spiritual, mental, emotional and physical well-being. NPs in the 
clinical setting have a great influence on patient care and the 
management of CMP. The results of this study illustrate that 
NPs have minimal/fair knowledge on the use of CAM in the 
management of CMP. A thorough pain assessment to 
determine the onset, location, duration, aggravating and 
relieving factors is the first step in understanding the patient’s 
needs. Patients should be educated while under the care of NPs 
on the use of a non-steroidal anti-inflammatory (NSAID), 
positioning techniques, the use of yoga, massage, chiropractics, 
or acupuncture in adjunct to their treatment plan prior to 
attempting treatment with opioids. 
The combination of CAM therapies and conventional 
medicine presents a holistic approach that considers all factors 
that influence health, wellness, and disease – mind, body, and 
spirit. Implementing an integrative approach to medicine 
builds a partnership between patients and practitioners and 
allows them to recognize the use of natural, less-invasive 
intervention whenever possible. If NPs seek to expand their 
knowledge of CAM when approaching treatment options for 
CMP, they are becoming models for holistic treatment 
approaches to patient care. 
 
Conclusion 
A limitation to this study was the small sample size. 
Therefore, a larger study with an adequate sample is needed to 
further validate study findings. These findings indicate that NPs 
are in an optimal position to educate patients on the use of 
CAM therapies in order to manage CMP and minimize the 
need for opioid pain relief. This research indicates a need for 
NPs to be adequately educated on CAM and how to access 
them in order for their patients to receive a holistic approach to 
care and minimize the amount, strength, or frequency of opioid 
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Anxious People Report Less Emotional Distancing 
While Imagining Negative Future Events 
Cameron Scroggs 
 
Do you ever think about an upcoming event, like an 
upcoming exam or an important interview, in a way that makes 
you feel like you are experiencing the event now? Do your 
palms sweat or does your heart race as you imagine it 
unfolding? If imagining future events does make you anxious or 
worried, you are experiencing a natural response to a uniquely 
human ability. Referred to as episodic future thinking (EFT) 
(Schacter et al., 2007), foresight (Suddendorf, 2017), or 
prospection (Gilbert & Wilson, 2007), the ability to imagine 
upcoming events can be very beneficial to humans. It can 
protect us from entering dangerous situations and help us react 
to environmental threats (Bulley et al., 2017). It can also help 
people plan, make decisions, and even think creatively (Madore 
et al., 2018). 
Though the cognitive ability to imagine the future is 
beneficial, the feelings these mental simulations evoke may be 
unpleasant (Emery et al., 2019). Temporary anxious feelings 
are not necessarily problematic, but being chronically worried 
or anxious about the future can be harmful to our wellbeing. 
For example, worrying to the extent that it complicates day-to-
day functioning is common among people who have 
generalized anxiety disorder (Bulley et al., 2017). How, then, 
might people experience the benefits of episodic future thinking 
while controlling the unpleasantness of the experience? 
One possible method for reducing feelings of anxiety 
during EFT is mentally to place space between oneself and past 
events by adopting a “cognitively distant” perspective (Kross & 
Ayduk, 2011), as opposed to reliving an experience from an 
immersed, first-person perspective. This can be accomplished 
through increasing social distance (e.g., imagining yourself 
through the eyes of another or referring to yourself in third-
person language) or temporal distance (e.g., mentally 
broadening the scope of time and imagining how your future 
self would think about this event). The research literature on 
psychological distancing, however, is focused on remembering 
past events, rather than imagining future ones. It is therefore 
unknown whether distancing is an effective tool for reducing 
anxiety when thinking about the future. 
The primary goal of this thesis, therefore, was to 
investigate whether psychological distance has the same 
emotional impact while imagining future events that it does 
when remembering past events. A second goal was to 
determine whether individual differences in anxiety might 
moderate the impact of psychological distancing. Before 
turning to my study, I will review some of what is known about 
the relationships between distancing, anxiety, and future 
thinking, using a theoretical model of threat-related internal 
thought (Bulley et al., 2017) as a framework. 
 
The Costs and Benefits of Imagining the Future 
The human capability to defend against future threats is 
thought to be a result of cognitive and physiological 
advancement in our evolutionary history (Bulley et al., 2017; 
Suddendorf, 2018). The ability broadly referred to as internally 
generated thinking allows humans to prospectively consider 
future threats and retrospectively reproduce those that have 
already been endured, regardless of stimuli in the present 
environment (Bulley et al., 2017). That is, all animals can 
experience fear, which is a reaction to immediate and concrete 
threats in the environment. Humans, however, have the ability 
to imagine events that have not happened but might occur and 
experience anxiety in response to this imagined event. While 
having an excess of anxiety is harmful, Bulley et al. (2017) 
argue that having some anxiety may be beneficial for humans. 
They define anxiety as an internal response based on 
prospective (forward-looking) and/or retrospective (backward-
looking) thinking, in combination with cues of potential threat. 
These cues can be real or imagined. 
Internally generated thought is derived from a 
combination of episodic and semantic thinking. Episodic 
thinking is described as first-person, image-based thinking. 
Semantic thinking is an innate “knowing” without mental 
stimulation and is much more abstract and verbal than episodic 
thinking. The episodic and semantic content of thought is 
acquired by memories of past experiences but can be combined 
in new ways to think about the future (Schacter et al., 2007). As 
described by Bulley et al. (2017), “Semantic and episodic 
memories provide the ‘raw material’ from which prospective 
thoughts are construed” (p. 59). 
Most future thinking contains some amounts of both 
episodic and semantic content. Researchers make a distinction, 
however, between EFT and other types of more general future 
thought. Episodic future thoughts are mental imaginations or 
simulations of upcoming future events (Schacter et al., 2007; 
Wu et al., 2015). EFT dominates most of human thought and 
contains specific details with concrete mental imagery. For 
example, if someone describes the vacation they went on last 
summer, episodic details would include what they did and 
where (e.g., they flew a yellow kite on the beach), when (e.g., 
the first Wednesday of the vacation), and with whom (e.g., a 
grandparent). Episodic future thought differs from semantic 
thought. In comparison, the semantic version of the episodic 
example used above would sound something like this: “I 
enjoyed going to the beach.” Generally, EFT may help us plan, 
attain goals, and assist in prospective coping. As may be 
expected, EFT tends to contain more episodic information 
than semantic information, at least amongst young adults 
(Emery et al., 2019). When describing EFT that is specifically 
about threat, Bulley et al. (2017) suggest the term episodic 
threat prospection (ETP). ETP is often emotionally laden, 
which helps humans avoid threats, but is harmful to one’s 
welfare in some cases because of the way ETP negatively 
influences mood (Bulley et al., 2017). 
In contrast to EFT, other types of future thinking are 
dominated by semantic content. For example, worry about the 
future is a common feature of anxiety disorders (Bulley et al., 
2017). Kaplan et al. (2018) define worry as a response that is 
based on uncertainty or the potential for future problems to 
arise. Bulley et al. (2017) clinically defines worry as non-
concrete verbal depictions of future threats, which are reliant 
mostly upon semantic processes. This type of thinking is also 
known as semantic threat prospection and is common among 
individuals with generalized anxiety disorder (GAD). These 
thoughts are usually scarce in mental imagery and episodic 
content. Semantic worry aids in alerting an individual of a 
problem but is not particularly useful for problem-solving 
(Bulley et al., 2017). Prior research indicates that semantic 
threat prospection may help individuals cope with troublesome 
effects of anxiety that are commonly elicited by episodic threat 
prospection. That is, worry may be an avoidant response to the 
negative feelings evoked by imagining a specific future event 
(e.g., Borkovec et al., 1998). Worry may therefore reduce 
immediate anxious feelings but impair one’s ability to take 
active steps to avoid the very threat one is worried about. 
Episodic and semantic threat prospection are thought 
to arise from their companion processes of episodic and 
semantic threat memory. A more common name for semantic 
threat memory is rumination. Kaplan et al. (2018) define 
rumination as a negatively valenced, uncontrollable repetitive 
thinking process, usually focused on self- and past-experiences, 
which occur independently of external stressors. In other 
words, to ruminate is to think chronically about the effects of 
one’s past negative experiences. According to Ayduk and Kross 
(2010), when humans feel an emotion, there is often an urge to 
analyze and understand the emotion (that is, what are the 
feelings and why are they happening), but analyzing feelings 
and ruminating on them in this way can worsen gloomy 




Kross et al. (2005) state that attempting to analyze 
negative emotions (e.g., anger or sadness) can be maladaptive 
in that it can lead to rumination. Engaging in rumination often 
leads to long term increases in negative affect. Preventing 
rumination should entail processing negative emotions in a 
more abstract manner to be managed in a distant, 
contemplative fashion. Kross et al. (2005) suggested two factors 
that may affect one’s capacity to cognitively depict negative 
feelings this way: self-perspective (immersed vs. distanced) and 
affective focus, which examines the subject matter of one’s 
thoughts regarding one’s emotional experiences. Previous 
emotional distancing research by Ayduk and Kross (2008) 
indicates that recalling negative events from a psychologically 
distant outlook (as opposed to the immersed perspective of 
“reliving” the experience) reduces negative emotions. When 
dealing with negative experiences, a person can decenter 
themselves from experiences and view experiences from a 
“third-person perspective” (Kross et al., 2005, p. 710). The 
distanced outlook helps people process emotional experiences 
by reflecting on them rather than negatively reacting to 
emotional arousal. 
While initial research on psychological distancing 
focused on remembering events from a socially distant, third-
person perspective, more recent research has looked at how 
temporal distancing (viewing a recent event from the point of 
view of a distant future self) can also reduce negative emotion. 
For example, one recent study examined the possibility that 
distancing oneself temporally may reduce negative affect in 
response to experiencing directly a negative event, and that it 
may help individuals cope. Bruehlman-Senecal and Ayduk 
(2015) examined whether expending cognitive resources by 
focusing on how impermanent negative events are (through the 
process of placing temporal distance between the current 
negative effects versus future impact) reduces anxiety. 
Bruehlman-Senecal and Ayduk (2015) created an 8-
item psychometric measure, the Temporal Distancing 
Questionnaire (TDQ), to assess the propensity to distance 
oneself from negative experiences by mentally broadening the 
scope of time. Doing so seems to make negative events feel less 
severe because temporal distance allows one to view the event 
as transitory. This construct is measured with questions like “I 
tell myself that this event probably won’t impact my life very 
far into the future” (Bruehlman-Senecal & Ayduk, 2015). The 
authors also measured whether or not engaging in temporal 
distancing promotes general welfare. Well- being was measured 
through various self-report scales concerning levels of 
optimism, satisfaction with life, and positive well-being. The 
findings supported the notion that temporally distancing 
oneself (i.e., adopting a distant-future perspective) indeed 
lessened the experience of current emotional distress 
(Bruehlman-Senecal & Ayduk, 2015). 
A recent study in our lab (Emery et al., 2019) also found 
that distancing oneself from everyday events (as opposed to 
negative ones) can promote positive emotion. In the study, 
adults of varying ages were asked to remember or imagine 
everyday events (e.g., getting a haircut) in two ways. In the 
immersed condition, participants were guided through the 
event itself, as if they were experiencing it through their own 
eyes. In the distanced condition, participants were asked to 
focus on how the event integrated into their overall life. When 
describing events in the distanced condition, participants 
reported more positive affect, used more positive words, and 
reported less immersion in the event than when describing 
events in the distanced condition. 
 
Anxiety and Episodic Future Thought 
A limitation of the temporal distancing literature is that 
the vast majority of studies focuses on past events rather than 
future ones. Because anxiety is evoked by imagining future 
events, it is unclear whether distancing would be as helpful for 
worry as it is for rumination. Highly anxious people, like those 
with GAD, tend to engage in both prospective and 
retrospective thinking that is generally more negatively 
valenced than that of non-anxious people (Wu et al., 2015). 
Common features of GAD include persistent, chronic worry 
about what may happen in the future, unwillingness to accept 
unpredictability, and beliefs like “worrying allows me to 
prepare for the future” (Wu et al., 2015). Wu et al. (2015) add 
that worry is a thinking style analogous to rumination, focused 
on the semantic rather than episodic content of future 
imagined events. 
Wu et al. (2015) hypothesized that it would be more 
difficult for highly anxious individuals to come up with 
detailed, negatively-valenced future events (as opposed to 
general, non-detailed events), think negative events were more 
likely to happen, and generally have a more negative outlook 
for the future. To test these hypotheses, researchers had 
participants generate extensive lists of familiar people, places, 
and things, select portable objects and specific locations, 
simulate a future event, and rate the plausibility of the event. 
They then returned for a second time and resimulated the 
events they previously constructed based on a valence tag of 
neutral, positive, or negative. This gave participants the chance 
to generate novel episodic future possibilities and then measure 
how likely the events were believed to be. Wu et al. (2015) 
found that it is easier for anxious individuals to produce 
negative future events than positive ones, come up with 
plausible reasons for the negative event’s occurrence, and feel 
that there is high likelihood that the future will hold more 
negative events. Contrary to predictions, the anxious and non-
anxious groups did not differ in their ratings of how detailed 
the negative events were when they simulated them. 
 
Current Study 
Broadly speaking, this study examined the relationship 
among anxiety, episodic future thinking, and temporal 
distancing. To my knowledge, no prior research has 
investigated relationships among these three constructs, largely 
because they arise from separate research traditions (clinical, 
cognitive, and social psychology, respectively). Based on the 
findings of Wu et al. (2015), I expected anxious individuals to 
engage in more negatively valenced episodic future thinking 
than non-anxious individuals. Based on the prior findings of 
Emery et al. (2019), I expected that individuals in the 
immersion condition would have increased feelings of negative 
emotion compared to people in the distanced condition. 
Finally, I hypothesized that the effect of anxiety on negative 




Participants were 73 Appalachian State University 
(ASU) students between the ages of 18 and 25 who were 
recruited through SONA, ASU’s psychology recruitment 
system. The only inclusionary criterion was that participants 
had to be young adults (18-25) currently enrolled at ASU. The 
final sample size was 53, as there were 17 participants who did 
not show up for Time 1, and three participants were excluded 
from analysis because the event they described was fewer than 
14 days (i.e., two weeks) away. The study was approved by 
ASU’s Institutional Review Board, and participants explicitly 
consented to being part of this study with knowledge they could 
stop at any point. Student participation in this study was 
voluntary but was incentivized by the possibility of earning two 
experiential learning credits (ELCs) that count toward course 
credit by completing the study. 
 
Materials 
Future Event Questionnaire 
Based on prior research (Ayduk & Kross, 2010; Ayduk 
& Kross, 2008; Bruehlman-Senecal & Ayduk, 2015), I used a 9-
item, modified version of the questionnaire developed by 
Emery et al. (2019) to measure both mood and emotion 
regulation strategies used while imagining future events. 
Participant mood (the primary dependent variable) was 
measured by assessing positive and negative affect (“As I was 
describing the event, I felt a lot of positive emotion” or “As I 
was describing the event, I felt a lot of negative emotion,” 
respectively). Immersion in the future event (the primary 
manipulation check) was measured with the item “As I was 
describing the event, I felt as if I was living the experience as it 
will be, through my own eyes.” The response scale ranged from 
1-6, where 1 = completely disagree and 6 = completely agree. 
 
Beck Anxiety Inventory (BAI) (Beck et al., 1988) 
A self-report scale by Beck et al. (1988) was used as the primary 
measure of anxiety in adult participants. The BAI is designed 
to assess an individual’s anxiety severity (Beck et al., 1988) and 
has been used to distinguish between anxious and non-anxious 
groups in prior research (Wu et al., 2015). The measure is a 21-
item, 4-point Likert-type scale where 0 = not at all and 3 = 
severely, it bothered me a lot. Participants were asked to ponder how 
much they have experienced these symptoms within the past 
month and answer accordingly. Sample items include 
“numbness or tingling” and “heart pounding/racing.” Internal 
consistency for the BAI was high (Cronbach’s α = 0.92), and 
test-retest reliability at one week for the BAI was adequately 
stable (r = 0.75; Beck et al., 1988). 
 
Exploratory Measures 
Two measures were included for exploratory purposes 
and are not reported in the analyses for the thesis. 
Follow-Up Event Questionnaire. One week after 
the test session, participants were asked to fill out another 
questionnaire about the event they imagined. The measure was 
a 14-item, 6-point scale where 1 = strongly disagree and 6 = agree. 
Sample items include “As I’m thinking of the event now, I am 
feeling a lot of negative emotion,” “I have put the event behind 
me completely,” and “This event still bothers me”. 
Anxiety Sensitivity Index-3 (ASI-3) (Taylor et 
al., 2007). Anxiety sensitivity was assessed by the ASI-3 by 
Taylor et al. (2007). The self-report index consists of 18 items 
designed to measure general anxiety sensitivity and three 
domains of apprehensions: cognitive (e.g., “When my thoughts 
seem to speed up, I worry that I might be going crazy”), 
physical (e.g., “When my throat feels tight, I worry that I could 
choke to death”), and social (e.g., “When I begin to sweat in a 
social situation, I fear people will think negatively of me”). 
Participants were asked to rate their level of agreement of each 
statement on a 5-point Likert-type scale where 0 = very little and 
4 = very much. The reliability and validity of the ASI-3 have 
been established, and there is indication that the psychometric 
qualities of the ASI-3 have been refined since the original ASI 
(Taylor et al., 2007). The total score is determined by 
calculating the sum of the 18 items, and scores range from 0-
72. A score of 0-17 is indicative of “almost no anxiety 
sensitivity”; 18- 35 indicates “low anxiety sensitivity”; 36-53 
indicates “moderate anxiety sensitivity”; and 54-72 indicates an 




 The experimenter began the study by briefly explaining 
the experiment procedure to the participant and obtained 
proper informed consent before continuing to the experiment. 
All procedures were approved by the ASU Institutional Review 
Board on Feb. 2, 2019. Participants completed the procedure 
individually in a quiet testing room with a single researcher 
present. 
This study consisted of two parts: an in-lab, in-person 
portion and an online follow-up survey. Upon arrival for the 
in-lab portion of the study, participants were seated and told 
about the informed consent process, and the researcher started 
video recording the participant to ensure the participant was 
adhering to task instructions. (Videos will be analyzed and 
coded at a later time). 
Participants were randomly assigned to one of two 
conditions: immersed (n = 27) or distanced (n = 26). In each 
condition, participants were read a prompt asking them to 
think of an upcoming event that they are anxious about. The 
prompt was adapted from a prior study by Ayduk & Kross 
(2010), but changed from remembering a personal conflict to 
imagining a worrisome event: 
No matter how well life is going, there are future 
events that we may be worried about. Take a 
few moments right now to think of an upcoming 
event that you may be anxious or concerned 
about—one that makes your heart race or palms 
sweat just thinking about. Although it may be 
difficult, most people can usually imagine at 
least one upcoming worrisome event that will 
come up in the future. Please try to imagine an 
experience that is at least two weeks, but no 
more than two months away. Take your time as 
you try to do this. Once such an event comes to 
mind let me know when you are ready to begin 
describing it. 
In the immersed condition, participants were asked to 
describe details of the surroundings, people, and actions 
involved in the event itself. In the distancing condition, 
participants were asked to describe how the surroundings, 
people, and actions of the event related to other events, people, 
and places they have previously experienced in life. These 
instructions had previously been used in the study by Emery et 
al. (2019). 
After describing the event, all participants completed 
three questionnaires: Future Event Questionnaire, BAI, and 
ASI-3. One week after the event, participants were sent out a 
follow-up questionnaire to fill out via an online survey. 
 
Results 
All data were analyzed using an Analysis of Covariance 
(ANCOVA) with Condition (Immersed vs. Distanced) as the 
independent variable and BAI scores as the covariate.  
 
Manipulation Check 
For the question about how immersed people were in 
the event, there was no main effect of condition, F(1,49) = 
1.050, p = 0.311, ηp2 = 0.021, no Condition x Anxiety level 
interaction, F(1,49) = 1.165, p = 0.286, ηp2 = 0.023, but there 
was a main effect of anxiety, F(1,49) = 6.686, p = 0.013, ηp2 = 
0.120. Immersion ratings did not differ between the Immersed 
(M = 4.67, SD = 1.14) and distanced conditions (M = 4.65, SD 
= 1.02). This suggests that the manipulation did not have its 
intended effect. Anxiety level, however, was moderately and 
positively correlated with the amount participants felt 




Negative and Positive Feelings 
For negative affect reported while describing the event, 
there was there was no main effect of condition, F(1,49) = 
0.571, p = 0.454, ηp2 = 0.012, no main effect of anxiety level, 
F(1,49) = 1.42, p = 0.283, ηp2 = 0.028, and no Condition x 
Anxiety Level interaction, F(1,49) = 0.045, p = .833, ηp2 = 
0.001. Besides being not statistically significant, the effect of 
condition was in the opposite direction that was predicted. 
Participants reported more negative affect while describing the 
event under distancing instructions (M = 3.58, SD = 1.27) than 
immersion instruction (M = 3.15, SD = 1.29). 
For positive affect while describing the event, there was 
there was no main effect of condition, F(1,49) = 1.901, p = 
0.174, ηp2 = 0.037, no main effect of anxiety level, F(1,49) = 
0.005, p = 0.946, ηp2 = 0.00, and no Condition x Anxiety Level 
interaction, F(1,49) = 0.684, p = 0.412, ηp2 = 0.014. As with 
negative affect, the effect of condition was in the opposite 
direction of what was predicted: Participants reported more 
positive affect while describing the event under immersion 
instruction (M = 3.37, SD = 1.18) than distancing condition (M 
= 2.88, SD = 1.42). 
 
Other Important Event Characteristics 
These results found only that highly anxious people 
reported more immersion while imagining the events. They did 
not, however, differ in how they felt while describing the event 
from low-anxious participants. To investigate possible reasons 
for this apparent discrepancy, I investigated data from two 
other questions in the future events questionnaire. 
First, one question asked about how much the 
participant had thought about the event before coming into the 
lab. For this variable, there was there was no main effect of 
condition, F(1,49) = 0.070, p = 0.793, ηp2 = 0.001, a main effect 
of anxiety, F(1,49) = 25.57, p < 0.001, ηp2 = 0.343, and no 
Condition x Anxiety Level interaction, F(1,49) = 0.014, p = 
0.908, ηp2 = 0.00. The amount someone considered the event 
before coming into the lab was strongly positively correlated 
with both their anxiety level, r(51) = 0.59, p < 0.001. It appears, 
therefore, that high and low-anxious people differed 
substantially in how often they had thought about the event in 
the past. 
In addition, participants were asked how far in the 
future the event was. This open-ended response was converted 
into a number of days for analysis. For the amount of time 
before the event occurs, there was there was no main effect of 
condition, F(1,49) = 0.850, p = 0.361, ηp2 = 0.017, no main 
effect of anxiety, F(1,49) = 0.462, p = 0.50, ηp2 = 0.009, and no 
Condition x Anxiety Level interaction, F(1,49) = 0.290, p = 
0.593, ηp2 = 0.006. 
 
Discussion 
In this study, I investigated whether emotional 
distancing decreased negative feelings about future events and 
whether this effect was moderated by participants’ anxiety 
levels. Based on previous research, I expected anxious 
individuals to feel more negative when imagining anxiety-
provoking negative events than non-anxious individuals (Wu et 
al., 2015). Second, I expected individuals in the immersed 
condition to have increased negative feelings when describing 
the event than participants in the distanced condition. Finally, I 
expected the difference between high- and low-anxious 
participants to be larger in the immersed than distanced 
condition. None of these hypotheses, however, was supported 
by the data. 
Interestingly, I did find that participants who scored 
higher on the BAI immersed themselves more in describing the 
upcoming worrisome event. Further, I found that more anxious 
individuals reported thinking about the event before coming 
into the lab more than non-anxious individuals. However, 
statistical analyses indicated that participants’ anxiety levels did 
not predict how negative they felt while describing the event, 
regardless of condition assignment (immersed or distancing). 
Moreover, the amount of negative affect induced was 
surprisingly low: On a 6-point scale, the average negative affect 
rating was just over the midpoint of 3. This suggests that my 
attempt to induce anxiety through episodic future thinking was 
unsuccessful. It is possible that by thinking about the event 
beforehand allowed highly-anxious participants to rehearse 
details of the event and engage in emotion regulation strategies, 
which may explain why they did not report feeling anxious 
while describing the event in the lab. These findings support 
prior research by Wu et al. (2015) and Bulley et al. (2017) in 
that anxious individuals did report thinking about (and likely 
ruminating and/or worrying about) the event more than non-
anxious individuals. 
One surprising finding of the study was that the 
distancing instructions were ineffective at changing either 
participants’ immersion or mood. On one hand, this finding is 
somewhat consistent with the findings from Wu et al. (2015) 
that anxiety level did not moderate the level of detail produced 
when imagining future events. That is, the way people think 
about anxiety provoking future events may be relatively 
impervious to either individual differences or experimental 
manipulations. On the other hand, these instructions have 
successfully changed people’s sense of immersion and mood in 
a previous study (Emery et al., 2009). In that study, however, 
the events people imagined were mostly positively valenced and 
cued by focusing people on event content rather than event 
emotion. Finally, even though mood differences between 
conditions were not statistically significant, they were actually 
in the opposite direction as predicted: Participants in the 
distanced condition reported more negative and less positive 
affect while describing the event than people in the immersed 
condition. This did not align with the findings of Bruehlman-
Senecal and Ayduk (2015) that adopting a distant-future 
perspective lessened the experience of current emotional 
distress. 
There were several limitations to the current study that 
should be addressed in future research. First, a clear limitation 
of this study is the small sample size (N = 53). Future research 
should attempt to recruit a larger sample size, as the results 
could reflect a “power issue” (i.e., the need for a larger sample 
to detect effects) in detecting the differences in mood evoked by 
the conditions. Another potential limitation of the study is that 
I did not attempt to control the extent to which participants 
thought about the event before coming into the lab for Time 1, 
which may have affected the way they processed negative 
emotions beforehand. This could be controlled by using a 
procedure like that used by Wu et al. (2015). Lastly, using a 
sample that is not clinically diagnosed with anxiety could be 
problematic in that the results are not generalizable to clinical 
populations. The results may have been different if the 




In sum, the current study finds that participants who 
scored higher on the BAI immersed themselves more in 
describing an upcoming worrisome event. The nature of this 
effect likely depends on how much a person thinks about (i.e., 
cognitively rehearses) a worrisome upcoming event before its 
occurrence, as well as how anxious a person is in general. In 
addition, instruction to either immerse or self-distance oneself 
from negative emotional experiences has the potential to 
increase feelings of anxiety. These preliminary findings suggest 
that anxious people may ruminate on negative emotional 
experiences when considering future events more than non- 
anxious individuals. 
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Investigating the Relationship between 
Anxiety Sensitivity and Chronic Illness: 




Chronic illnesses (or noncommunicable diseases 
[NCDs]) are those that cannot be passed from person to 
person, but instead slowly progress throughout the lifetime of a 
single individual. Worldwide, NCDs were responsible for 68% 
of the world’s 56 million deaths in 2012, with more than 40% 
of the deaths being considered premature (World Health 
Organization [WHO], 2014). In the United States alone, more 
than 117 million adults, almost half of the population, have 
been diagnosed with at least one NCD, with one in four adults 
having two or more NCDs (Ward et al., 2014). Chronic 
illnesses account for most of the annual healthcare costs in the 
United States, consuming 86% of the country’s annual 
healthcare budget, totaling over $2.3 trillion (Gerteis et al., 
2014).  
The overall burden of NCDs can be measured using 
Disability Adjusted Life Years (DALY). This measure combines 
years of life lost (YLL) and years lost to disability (YLD). 
Together DALYs are a measure of how many years of life are 
lost due to death, illness, or impairment (Murray et al., 2012). 
In 2015, almost 80,000 years were lost per 100,000 people in 
the United States due to NCDs. Fifteen percent of the years 
lost can be attributed to mental diseases, while the other 85 
percent are from chronic physical illness (WHO Department of 
Information, Evidence and Research, 2016). Research has 
shown that there is a common comorbidity between mental 
disorder and chronic physical illness (Tsang et al., 2008). 
Comorbidities can exacerbate the disease condition. Verbrugge 
et al. (1989) found that as the numbers of comorbidities 
increase, disability rises exponentially.  
Anxiety disorders are the most common mental illness 
in the United States (Facts & Statistics, 2017), and comorbidity 
between chronic illness and anxiety disorders are fairly 
common. Katon et al. (2006) reviewed 31 studies regarding the 
association between chronic illnesses and anxiety/depression, 
finding that any person with a diagnosed chronic illness and 
comorbid anxiety disorder generally perceive more symptoms 
of the disease than those without anxiety. Chronically ill 
populations also appear to exhibit heightened awareness of 
physical symptoms. The burden of comorbid anxiety disorders 
and chronic illnesses is more likely to increase anxiety 
symptoms and worsen episodes on top of the taxing symptoms 
of the disease (Katon et al., 2006).  
The American Heart Association (2013) reports that, in 
the United States, one out of every three persons is 
hypertensive. Hypertension causes stress to the arteries in the 
body, and a comorbidity with anxiety may increase that stress 
leading to a higher rate of mortality. In a review conducted by 
Pan et al. (2015), the researchers found a significant 
relationship between anxiety and hypertension in cross-
sectional studies. In addition, there was a direct association 
seen in prospective studies that were included in the review. 
They also concluded that those with anxiety were at an 
increased risk for hypertension although there are other 
variables that come into play. In a study conducted with middle 
aged men, a similar result was seen. Generalized Anxiety 
Disorder (GAD) was found to be positively associated with 
hypertension (Carroll et al., 2009). Their data suggested that 
the comorbidity of GAD and hypertension was not synergistic, 
but was acting additively, resulting in an increased disease 
burden (Carroll et al., 2009). 
In the United States alone, more than 28 million adults 
have been diagnosed with heart disease. In addition, it is the 
number one cause of death among Americans (National Center 
for Health Statistics [NCHS], 2021, March 1). The morbidity 
and mortality of cardiovascular disease makes understanding of 
associated factors and risks a priority. Vogelzangs et al. (2010) 
researched the association between the presence of an anxiety 
or depressive disorder and cardiovascular disease. They found 
that anxiety and cardiovascular disease are associated. Their 
study also examined the relationship with coronary heart 
disease, which is the most common form of cardiovascular 
disease (Heart Disease, 2017). The study found that the 
prevalence of coronary heart disease increased over a variety of 
anxiety diseases. Those who had an anxiety disorder in the past 
year were up to three times as likely to suffer from coronary 
heart disease. They further examined the amount of time that 
persons had been diagnosed with anxiety disorders and found 
that there was no significant evidence relating length of 
diagnosis with increased cardiovascular disease (Vogelzangs et 
al., 2010).  
High cholesterol is a strong risk factor for the 
development of cardiovascular disease. With the relationship of 
anxiety disorders and cardiovascular disease, it is important to 
understand if there is a relationship with risk factors as well. 
Over one third of the adult American population has high 
cholesterol with less than half of those receiving treatment 
(Division for Heart Disease and Stroke Prevention, 2015). 
Rafter (2001) completed a study with the intention of finding 
biochemical markers for anxiety and depression and found that 
high total cholesterol is related to anxiety. In another study, 
Peter et al. (2002) found that cholesterol levels were 
significantly higher in subjects with an anxiety disorder or 
OCD than normal control subjects. A more detailed 
comparison of the population with anxiety disorders showed a 
significant increase in LDL and a significant decrease in HDL. 
Of the patients with anxiety disorders, 68% had borderline or 
high cholesterol compared to 30% of control subjects. This 
data led to the assumption that elevated cholesterol levels are 
generally associated with anxiety disorders (Peter et al., 2002).  
Arthritis is the leading cause of disability in America, 
affecting more than 50 million adults, with 30 million of those 
having osteoarthritis (Arthritis Foundation, n.d.). Research 
suggests that chronic pain and anxiety disorders are highly 
comorbid. A study investigating the link between anxiety and 
three chronic pain conditions found that there was a significant 
association that lasted through adjustments for different 
confounding variables (McWilliams et al., 2004). Similarly, 
VanDyke et al. (2004) found that trait anxiety was significantly 
higher in individuals with rheumatoid arthritis than those with 
osteoarthritis. In addition, as seen in the research on 
cardiovascular disease, disease duration was not found to be 
statistically significant in level of anxiety (VanDyke et al., 2004). 
This indicates that the presence of anxiety was simply related to 
the presence of disease and was not impacted by the length of 
time the individual had been diagnosed.  
Hypervigilance is one factor that could increase anxiety 
in those with NCDs. Those with chronic illness tend to be 
hypervigilant regarding symptoms and sensations (McDermid 
et al., 1996). Chronic illnesses often lead to a variety of sensory 
experiences that might alert the individual to when something 
is wrong within the body. While a patient might know to watch 
for these symptoms, they can be anxious and become 
hypervigilant, feeling symptoms that are provoked by the 
anxiety and not related to the illness. Anxiety sensitivity (AS) 
refers to fears of anxiety-related sensations due to beliefs that 
the sensations are associated with negative physical, 
psychological, or social outcomes (Reiss et al., 1986). Wong et 
al. (2014) found in chronic pain patients that pain 
hypervigilance mediates the relationship between AS and 
catastrophizing pain. For instance, a hypervigilant patient with 
lung disease may sense shortness of breath after a bout of 
movement more than a healthy patient would in the same 
situation. The patient with the illness may perceive this to be a 
sign that the condition of their lungs is deteriorating and 
become anxious. They may catastrophize this feeling into 
believing their lung collapsed or they are experiencing some 
other serious medical problem. In this case, hypervigilance can 
be maintained in the patient’s AS, which itself has been marked 
as a risk factor for anxiety disorders (Zvolenskya et al., 2006).  
As mentioned above, AS is a risk factor for the 
development of various anxiety disorders. AS is the fear of 
anxiety symptoms that comes from the belief that anxiety may 
result in physical harm (Reiss, 1991). Furthermore, AS has 
been broken down into three factors, physical concerns, social 
concerns, and psychological or cognitive concerns (Zinbarg et 
al., 1997). Physical AS includes the belief that physical 
symptoms may be a sign of illness and the fear that results from 
that belief. Social AS is fear that others can observe the anxiety 
symptoms and it will result in embarrassment or ridicule. 
Lastly, psychological AS is fear that cognitive anxiety 
symptoms are proof of mental incapacitation (Stewart et al., 
1997). The study done by Zinbarg et al. (1997) showed that 
increased physical AS was associated with greater rates of panic 
disorder, while higher social AS was associated with social 
phobia. Increased cognitive AS on the other hand, was not 
related to a single anxiety disorder, but differentiated diagnosis 
of an anxiety disorder from that of no anxiety disorder, with 
the exception of simple phobia (Zinbarg et al., 1997). Reiss and 
McNally (1985) propose that AS is an individualized 
personality factor relevant in the development of anxiety 
disorders. AS has been found to be an identifier for substance 
abuse (Stewart et al., 1999), PTSD (Marshall et al., 2010), 
panic (Maller & Reiss, 1992), and agoraphobia (Wardle, 
Ahmad, & Hayward, 1990). These four associations show 
importance in their link to chronic illness.  
Often those who have been diagnosed with a chronic 
illness are prescribed several types of medications and in some 
cases might try to self-medicate. Stewart et al. (1999) investigate 
the links between various substances being used and abused 
and their link with AS. Their review suggested a relationship 
between AS and misuse of substances such as benzodiazepines 
and analgesics that are commonly prescribed to those with 
chronic illness. Because of a link between high AS and 
substance use and the possible link between AS and chronic 
illness, AS may be a marker predicting substance misuse and 
abuse among a chronically ill population.  
PTSD may also be linked to chronic illness. A patient 
with chronic illness may experience a spell related to their 
disease that is later traumatizing to them. This traumatization 
may cause them to avoid certain situations or places that 
produce symptoms similar to those that occurred at the time of 
their spell. That scenario shows the relationship between high 
AS and PTSD. Furthermore, research has shown that AS can 
predict future PTSD symptoms. Therefore, patients with high 
AS are less likely to see a decrease in their PTSD symptoms 
over time than their counterparts with low AS (Marshall et al., 
2010). If research proves a link between AS and chronic illness, 
it could be seen that the chronically ill population would 
maintain higher rates of PTSD.  
Another demonstrated association with high AS is panic 
disorder. AS was proven to predict the number, frequency, and 
intensity of future panic attacks in a study done by Maller and 
Reiss (1992). It is proposed that the relationship between AS 
and panic is a result of a misinterpretation of symptoms (Cox et 
al., 1999), in that a panic attack arises when an individual 
interprets what they are feeling as much more perilous than it 
actually is. This concept relates back to the topic of 
hypervigilance mentioned earlier. In the case of a chronically ill 
person, they may experience a rapid heart rate as a result of a 
stimulus and believe themselves to be having a heart attack 
leading themselves to panic. Hypervigilance led them to have 
increased awareness of their increased heart rate, and AS led 
them to become anxious about the possibility of what their 
symptom could mean. The increased anxiety led the patient to 
panic over an otherwise normal stimulus response. Because AS 
has been found to predict panic (Maller & Reiss, 1992), it 
serves a salient role in determining the risk of panic disorder in 
those who are chronically ill.  
Similar to panic, agoraphobia has also been found to 
have a link with AS (Wardle et al., 1990). Agoraphobia is the 
fear of places and situations that may lead to a feeling of being 
trapped, embarrassment, or otherwise related to increased 
anxiety. Wardle et al. (1990) found that agoraphobia is highly 
linked with AS markers regarding bodily symptoms. Therefore, 
an individual with agoraphobia would avoid a place if it had 
the possibility of causing a symptom to arise. In regard to the 
example given above, a person with chronic illness and high AS 
might know that their heart rate increases around groups of 
people, so they will avoid a sporting event, for instance, 
because they feel an increased heart rate will lead to heart 
attack. Knowing whether AS serves as a link between 
agoraphobia and chronic illness can lead to the understanding 
of why chronic illness causes a stark decrease in quality of life 
by determining if enjoyable experiences are being avoided for 
fear of anxiety sensations.  
The studies that have been done regarding relationships 
between anxiety disorders and high AS have a significant role 
in the research of AS in chronically ill populations. If a 
relationship between chronic illness and AS holds true, the 
links described earlier can identify possible comorbidities 
increasing impairment and decreasing quality of life. By 
understanding these relationships, better treatment and care 
may be provided. In addition, recognition of common 
comorbid disease could decrease medical spending.  
Very few studies have examined the relation between 
AS and chronic illnesses. Norman and Lang (2005) noted that 
AS could be a characteristic that was present before an illness 
was diagnosed but also that high AS may have developed as a 
result of the diagnosis. They utilized a sample of 389 
participants gathered from Veterans Affairs and university 
primary care clinic waiting rooms. Their sample was fairly 
evenly split between men and women; about 54% of their 
sample was Caucasian; and 55% had been diagnosed with at 
least one chronic illness. In their study, they noted limitations 
that may have played a role in their study, upon which  we 
plan to improve. Norman and Lang utilized the original ASI 
measure for its brevity. They suggested that a more 
comprehensive measure be used; therefore, we used the ASI-3.  
In the previous study, AS was found to have a role in 
the functioning of patients with hypertension, heart disease, 
and high cholesterol. The current study expected comparable 
results to the previous research that showed AS is higher in 
patients diagnosed with one or more chronic illnesses. Because 
little research has been done on this topic, this study will serve 
to reinforce the idea that AS plays a role in the diminished 
functioning of chronically ill patients. The importance of 
replication is strengthened by the common comorbidities seen 
between chronic illness and anxiety disorders (Roy-Byrne et al., 
2008). This study aims to determine if the linking factor is, in 
fact, AS by replicating the results of Norman and Lang (2005), 
with the exception of functioning and neuroticism. This study 
evaluated functioning based on the WHO’s Quality of Life 
measure (WHOQOL), and neuroticism was replaced by 
negative affect, which was measured with the Brief Symptom 
Inventory 18 as general distress. Based on the results of 
Norman and Lang (2005), we hypothesized that we would see 
an association between higher AS and the chronic diseases 
studied in our research. In addition, we further hypothesized 
that in the population with chronic illness physical AS would be 
higher and quality of life will be decreased.  
 
Method 
The data for this study were previously collected for 
another study (see Shanely et al. [2010] for clinical trial details). 
The data represent a large sample of 1,002 residents from a 
community in western North Carolina. Of the 1,002 
participants recruited by mass advertising, 941 completed all 
study requirements, including cognitive testing at baseline and 
post treatment. Additionally, 42 participants were excluded 
from the calculations for high cholesterol due to insufficient 
data. Ninety-five percent of participants were 
white/Caucasian, 1.8% were African American, and the 
remaining 3.2% were of other racial and ethnic background. 
Approximately 60% of the participants sampled were women. 
The age range of participants was 18 to 85 with a mean of 
45.96 (SD = 16.27). During recruitment, ages were stratified to 
ensure that various age ranges had adequate representation. 
Forty percent of subjects recruited were between the ages 18-
40, 40% were middle aged (41-65), and the remaining 20% 
were 66-85 and considered older aged adults. In addition to 
being stratified by age, participants were also stratified by body 
mass index (BMI). Thirty-three percent were considered 
normal BMI (18.5- 24.9), 33% were considered overweight (25-
29.9), and the remaining 33% were obese with BMI over 30. 
Almost 98% of the participants recruited had completed a high 
school education and 56% had earned a college degree.  
Subjects completed a Brief Symptom Inventory (BSI), 
the ASI-3, WHOQOL, and a health questionnaire. The ASI-3 
is an 18 item self-report measure that was designed to measure 
fear of physiological arousal-related sensations (AS). The ASI-3 
improved upon the ASI by focusing on three subscales, each 
with six items: Physical (e.g., “It scares me when my heart beats 
rapidly”), Cognitive (e.g., “It scares me when I am unable to 
keep my mind on a task”), and Social Concerns (e.g., “It is 
important for me to not appear nervous”). Each question is 
answered on a 0-4 point Likert scale (0 = very little, and 4 = 
very much) (Taylor et al., 2007). The BSI included questions 
regarding how the individual felt in that moment. The BSI’s 
general distress measure is also being used to predict negative 
affect. Research shows that the three subscales of the BSI are 
positively correlated with negative affect (Serafini et al., 2016). 
Quality of Life was measured using the WHOQOL. The 
WHOQOL has 115 questions and gathers information based 
on each individuals’ perception of their place in life in the 
context of their values and culture relating to their goals and 
expectations. Lastly, the health questionnaire included 
demographic questions, medical history questions, a self-report 
on chronic disease, risk factors for chronic disease, and 
questions about lifestyle. Around 38% of participants reported 
a history including one or more chronic disease. Twenty-eight 
percent of participants reported having one chronic disease, 
8.9% reported two, and 0.8% reported three or more. Chronic 
diseases to be considered in this study and the respective 
percentage of persons afflicted include heart disease (1.9%), 
hypertension (18.3%), high cholesterol (12.4%), and arthritis 
(15.5%). The breakdown of diseases and their respective AS 
and quality of life scores can be seen in Table 1.1 These four 
diseases were chosen based on their inclusion in the previously 
done study done by Norman and Lang (2005).  
 
1 The table, “Breakdown of Chronic Illnesses with AS and 
Quality of Life Scores,” is available online: 
http://libres.uncg.edu/ir/asu/f/Berdal_%20Emily%20Spring
%202018%20Thesis.pdf (p. 13). 
 
Analysis 
Hierarchical logistic regression analyses were performed 
to determine whether the three subfactors of AS predicted 
unique variance in each of the chronic illnesses over and above 
demographic variables and negative affect. Each chronic illness 
served as a dependent variable in one analysis. At Step 1, age, 
gender, and the BSI General Distress subscale were entered 
into the regression model. Participants’ scores on the Physical, 
Cognitive, and Social Concerns subscales of the ASI-3 were 
entered at Step 2, consistent with methodology used by 
Norman and Lang (2005). Age was included because there 
tends to be a higher prevalence of chronic illness as age 
increases. Also, chronic illnesses affect each gender at different 
rates (e.g., more women are diagnosed with arthritis than men 
[Arthritis Foundation, n.d.]). Watson and Pennebaker (1989) 
found that negative affect was significantly correlated with 
health complaints. Therefore, we included negative affect in 
the model. The selected variables were also chosen based on 
their inclusion in the previous study that is being replicated 
(Norman & Lang, 2005).  
Furthermore, a separate hierarchical regression analysis 
was conducted to determine if AS scores predicted the number 
of chronic illnesses. In this analysis, the number of chronic 
illnesses was the dependent variable, and the entry of indicator 
variables was the same as described above. 
Lastly, a hierarchical multiple regression analysis was 
conducted to determine whether AS subscale scores predicted 
quality of life over and above demographic variables and 
negative affect among individuals who met criteria for one or 
more chronic disease. Scores on the WHOQOL-BREF served 
as the independent variable, and the predictor variables were 
entered into the model as described above. 
 
Results 
Correlational analysis was used to examine a general 
relationship between chronic illness and AS, as well as 
demographic variables and negative affect. Preliminary results 
indicated weak relationships between age and chronic illness. 
Other weak associations were seen between chronic illness and 
AS and negative affect. The correlational analysis also 
indicated relationships between number of diseases and AS, 
demographic variables, and negative affect. Quality of life was 
seen to have a relationship with the same variables (Table 2).2  
The overall logistic regression analyses for 
hypertension, high cholesterol, arthritis, and heart disease were 
significant. In the final models, age was a significant predictor 
of each chronic illness, and gender significantly predicted all 
except heart disease (p = .059). However, the ASI-3 Physical 
Concerns subscale was only associated with hypertension after 
controlling for demographic variables and negative affect (p < 
.01), and the Cognitive Concerns subscale was only associated 
with high cholesterol (p = 0.02). The Social Concerns subscale 
did not predict any of the chronic illnesses, and none of the 
ASI-3 subscales predicted heart disease or arthritis. The results 
of the linear regression analyses can be seen in Table 3.3 
Our second aim was to determine if the AS predicted 
the number of chronic illness endorsed. The overall regression 
model was significant, but, in the final model, only age and 
gender significantly predicted number of chronic diseases 
(Table 4). 
A hierarchical multiple regression analysis was 
conducted to determine if AS subscale scores predicted quality 
of life among individuals with chronic illnesses (n = 393). The 
overall regression model was significant, and, in the final 
model, age, BSI-General Distress, and ASI-3 Cognitive 
 
2 The table, “Correlation of Variables,” is available online: 
http://libres.uncg.edu/ir/asu/f/Berdal_%20Emily%20Spring
%202018%20Thesis.pdf (p. 14).  
3 The table, “Chronic Illness and the Three Subscales of AS 
with Co-variates,” is available online: 
http://libres.uncg.edu/ir/asu/f/Berdal_%20Emily%20Spring
%202018%20Thesis.pdf (p. 15). 




The results from the current study suggest that certain 
chronic illnesses may be associated with the subfactors of AS. 
We found that physical AS was predictive of hypertension and 
cognitive AS was predictive of high cholesterol. However, 
neither of the other two illnesses that we studied had a 
significant relationship with any subfactor of AS. This could 
suggest that certain illnesses present with specific signs and 
symptoms that could increase AS, instead of the presence of 
illness in general impacting AS. Symptoms related to 
hypertension are commonly physical in nature and align closely 
with physical AS subscale questions (e.g., “When I feel pain in 
my chest, I worry that I am going to have a heart attack,” or 
“When I notice my heart skipping a beat, I worry that there is 
something seriously wrong with me”). While hypertension is 
mainly asymptomatic, two possible symptoms are chest pain 
and irregular heartbeat, matching the ASI-3 questions. While 
heart disease has similar symptoms, only a small percentage 
(<2%) of our sample had been diagnosed, which is not 
representative of the total heart disease population.  
While no relationship was found between physical AS 
and high cholesterol, we did find that cognitive AS was a 
predictor, which could be explained by the relationship of high 
cholesterol with cognitive decline, dementia, and Alzheimer’s 
Disease. Anstey et al. (2008) conducted a systematic review of 
prospective studies and found that high total cholesterol could 
be linked to declines in cognitive abilities, such as dementia and 
Alzheimer’s. They found this correlation to be especially true if 
high cholesterol was reported in middle-aged adults. High 
 
4 The table, “Anxiety Sensitivity Predicts Number of Chronic 
Illness and Quality of Life,” is available online: 
http://libres.uncg.edu/ir/asu/f/Berdal_%20Emily%20Spring
%202018%20Thesis.pdf (p. 16). 
cholesterol’s role in cognitive decline could explain why there is 
a significant relationship with cognitive AS.  
Arthritis was found to have no relationship with any 
subfactor of AS. As opposed to the other three chronic illnesses 
analyzed in this study, no symptom of arthritis is specifically 
outlined by the ASI-3 questions, thus eliminating the possibility 
of increased AS due to specific symptoms. Norman and Lang 
(2005) explained that the lack of significant relationship could 
also be due to the symptomatic nature of the disease. 
Hypertension, heart disease, and high cholesterol are mainly 
asymptomatic, so when symptoms do arise they cause increased 
anxiety and AS. Arthritis patients often live with daily 
symptoms. Having constant exposure to symptoms may 
decrease the amount of anxiety and AS attributed to them over 
time. These are two possible explanations as to why AS cannot 
predict arthritis, but more research is needed to further 
investigate possible relationships.  
The relationship between the presence of multiple 
chronic illnesses and AS was also investigated. Both physical 
and cognitive AS were related to the individual having more 
than one chronic illness. This relationship could be the result of 
a common comorbidity between hypertension and high 
cholesterol, where each illness raises their respective subfactor 
of AS as discussed earlier. These two illnesses have many of the 
same risk factors (i.e., sedentary lifestyle, unhealthy diet, and 
smoking), resulting in over half of all individuals with 
hypertension also being diagnosed with high cholesterol 
(American Heart Association [AHA], 2017). This result also 
suggests that AS increases as the disease burden increases. In 
addition, we found that in our chronically ill sample quality of 
life decreased as all subfactors of AS increased. This result 
implies that as disease burden grows so does functional 
impairment. A preliminary assumption can be made that the 
addition of AS to the normal physical burden of chronic illness 
increases both mental and social impairment as well. More 
research is needed to further investigate and better understand 
that relationship.  
The relationships that have been identified between AS 
and chronic illness indicate a need for increased education on 
the topic. The general public is widely unaware, first, of what 
AS is and, second, that it has an interaction with a physical 
chronic illness. Bettering education can help individuals 
understand aspects of anxiety and the realistic risk of anxiety 
related sensations, while learning about their disease and its 
signs and symptoms. This education can help individuals to 
more easily manage and cope with their illnesses. Education on 
the topic could also facilitate better interventions. Knowing the 
existence of a relationship between AS and chronic illness can 
lead to an interdisciplinary treatment plan that lowers overall 
disease burden. An unhealthy lifestyle is one of the main risk 
factors for chronic illness as a whole. Therefore, recognizing 
the relationship between AS and chronic illness reinforces not 
only the physical but mental benefits of a healthy lifestyle.  
This study was intended to be a replication of the 2005 
study performed by Norman and Lang. While some of our 
findings corresponded, the majority differed from their results. 
There are many things that could have contributed to the 
difference. For one, we utilized different measures. Where they 
used the original ASI we chose the ASI-3, which is more 
comprehensive in measuring the three subscales of AS. We also 
exchanged their neuroticism measure for general distress as 
measured by the BSI and substituted the WHO’s quality of life 
measure for functioning. While not likely to cause a dramatic 
difference in results, these substitutions may account for the 
discrepancies in results between the two studies. Our sample 
population also differed from that of the previous study, which 
could have led to differing results. The sample for this study 
had very little diversity and was mainly white. Females were 
also the majority in this sample, so gender differences could be 
a contributing factor. In addition to the differences in 
demographics, the samples were collected differently. The 
previous study pulled individuals from clinics in a larger city 
while this study took a community sample from a small town. 
The limitations to this study somewhat align with the 
reasons that were given for discrepancy in results between the 
two studies. A direct measure of neuroticism should be used. 
This study did not have access to a direct measure, so general 
distress as measured by the BSI took its place after research 
suggested it could be an adequate alternative. The sample for 
this study was also limited. In further research, a more stratified 
sample could be of benefit, as different illnesses present in other 
ethnic and socioeconomic groups. In addition, this study did 
not analyze gender differences; however, gender could play a 
key factor and its role should be further investigated. Another 
limitation to our study was small samples. For example, our 
heart disease sample was too small to confidently extrapolate 
the data to the entire population with heart disease. Larger 
sample sizes should be considered if further research should be 
done. The small R2 values discovered in our analysis suggest 
that other factors not examined in this may be contributing to 
the predictive relationships. Any later research should further 
investigate additional influences. Our cross-sectional design was 
another limitation to this study. We were not able to determine 
if chronic illness preceded the AS or vice versa because of the 
design. If possible, further research on this topic should attempt 
a longitudinal design. Any other research should also further 
investigate symptom-specific anxiety. As discussed above, 
certain illnesses have physical symptoms that make them more 
likely to answer physical AS subscale questions. While this 
study shows that there is a relationship between elevated AS 
and decreased functioning in chronically ill populations, 
additional research is needed to understand the extent of these 
relationships and the implications they could have for those 
with chronic illness.  
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I hope you know how special you are to me and 
everyone you met. You are a life changer, even after you 
passed your story has continued to touch so many lives. Thank 
you for never giving up on me; I know I was not easy to raise 
by any means. Thank you for giving me your voice to speak out 
bravely even if I was speaking alone. Thank you for your 
never-ending love and prayers, for I know those alone are what 
have kept me afloat all of this time. Thank you for your 
courage to fight against cancer, which is what allowed for our 
family to have as much time together as possible. 
I hope you know we miss you endlessly; we talk about 
you often, and we love you immensely. We laugh about the fun 
times and cry about the not-so-good times. You will always be 
missed and never forgotten, but you are especially missed when 
I experience milestones such as this one without you. 
I love you so much, keep looking out for us, and we will 
always continue to keep your spirit alive through us. 
Love, 
Your Oldest Daughter 
Dear Reader, 
I’m grateful to you for reading this book, for as you 
have seen, this book means a lot to me personally. My hope is 
that you, too, see that this book is more than just my senior 
project. It’s my way of honoring and remembering my mother, 
so that you might know that you’re not alone, that how you feel 
matters to your health, and that her death is not another 
statistic. I want her legacy to be valued, replicated in the lives of 
others who can feel empowered to do their own research, 
advocate for themselves, and seek “alternatives” to 
conventional medical and pharmacological treatments; she did 
her research and her advocacy to continue and help others.  
In America, when you say, “I’ve got cancer,” the first 
question you get is, “When do you start chemo?” That was my 
mom’s experience when she was diagnosed—but she didn’t 
accept the status quo. Not accepting the status quo is the basis 
of the questions and research that Emily Berdal, Courtney 
Phillips, and Cameron Scroggs—three among hundreds or 
thousands of Honors students across the country—shared with 
me and you in these pages.  
They are asking different questions—and asking 
different questions is what will lead us to different answers. 
These different answers are what is allowing all of us to have 
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